Screener
Jazz Pharmaceuticals JAZZ Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's asset turnover?
- Jazz Pharmaceuticals (JAZZ) reported asset turnover of 0.4× in Q1 2026.
- How has Jazz Pharmaceuticals's asset turnover changed year-over-year?
- Jazz Pharmaceuticals's asset turnover increased by 6.7% year-over-year, from 0.4× to 0.4×.
- What is the long-term trend for Jazz Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's asset turnover has grown at a -1.6% compound annual growth rate (CAGR), from 0.4× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Jazz Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude